Biogen scrapped stroke drug helps patients walk independently in Phase III trial

Biogen scrapped stroke drug helps patients walk independently in Phase III trial

Source: 
Clinical Trials Arena
snippet: 

A stroke drug scrapped by Biogen has helped more people to walk independently 12 months after a large hemispheric infarction (LHI), the most serious form of ischaemic stroke, in a Phase III trial.